Natural Product Chemistry of Gorgonian Corals of Genus Junceella—Part II by Wu, Yang-Chang et al.
Mar. Drugs 2011, 9, 2773-2792; doi:10.3390/md9122773 
 
Marine Drugs  
ISSN 1660-3397 
www.mdpi.com/journal/marinedrugs 
Review 
Natural Product Chemistry of Gorgonian Corals of  
Genus Junceella—Part II 
Yang-Chang Wu 
1,2, Jui-Hsin Su 
3,4, Tai-Ting Chou 
5, Yin-Pin Cheng 
5, Ching-Feng Weng 
3,6, 
Chia-Hung Lee 
3,6, Lee-Shing Fang 
7, Wei-Hsien Wang 
4,8,9, Jan-Jung Li 
4, Mei-Chin Lu 
3,4, 
Jimmy Kuo 
3,4, Jyh-Horng Sheu 
8,9,* and Ping-Jyun Sung 
3,4,6,8,9,* 
1  Graduate Institute of Integrated Medicine, College of Chinese Medicine, China Medical University, 
Taichung 404, Taiwan; E-Mail: yachwu@mail.cmu.edu.tw 
2  Natural Medicinal Products Research Center and Center for Molecular Medicine, China Medical 
University Hospital, Taichung 404, Taiwan 
3  Institute of Marine Biotechnology, National Dong Hwa University, Pingtung 944, Taiwan;  
E-Mails: x2219@nmmba.gov.tw (J.-H.S.); cfweng@mail.ndhu.edu.tw (C.-F.W.); 
chlee016@mail.ndhu.edu.tw (C.-H.L.); jinx6609@nmmba.gov.tw (M.-C.L.); 
jimmy@nmmba.gov.tw (J.K.) 
4  National Museum of Marine Biology and Aquarium, Pingtung 944, Taiwan;  
E-Mails: whw@nmmba.gov.tw (W.-H.W.); jj@nmmba.gov.tw (J.-J.L.) 
5  Uni-President Biotech Co., LTD., No. 31, Gongye 2nd Rd., Annan District, Tainan 709, Taiwan;  
E-Mails: tong.xin@msa.hinet.net (T.-T.C.); pin@unibiotech.com.tw (Y.-P.C.) 
6  Department of Life Science and Institute of Biotechnology, National Dong Hwa University, 
Hualien 974, Taiwan 
7  Department of Sport, Health and Leisure, Cheng Shiu University, Kaohsiung 833, Taiwan;  
E-Mail: lsfang@csu.edu.tw 
8  Department of Marine Biotechnology and Resources, National Sun Yat-sen University,  
Kaohsiung 804, Taiwan 
9  Division of Marine Biotechnology, Asia-Pacific Ocean Research Center, National Sun Yat-sen 
University, Kaohsiung 804, Taiwan 
*  Authors to whom correspondence should be addressed; E-Mails: sheu@mail.nsysu.edu.tw (J.-H.S.); 
pjsung@nmmba.gov.tw (P.-J.S.); Tel.: +886-7-525-2000 (ext. 5030) (J.-H.S.);  
+886-8-882-5037 (P.-J.S.); Fax: +886-7-525-5020 (J.-H.S.); +886-8-882-5087 (P.-J.S.). 
Received: 10 November 2011; in revised form: 6 December 2011 / Accepted: 15 December 2011 /  
Published: 19 December 2011  
 
Abstract: The structures, names, bioactivities, and references of 81 new secondary 
metabolites obtained from gorgonian corals belonging to the genus Junceella are described 
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in this review. All compounds mentioned in this review were obtained from sea whip 
gorgonian corals Junceella fragilis and Junceella juncea, collected from the tropical and 
subtropical Indo-Pacific Ocean. 
Keywords: Junceella; gorgonian; briarane; Indo-Pacific Ocean; South China Sea 
 
1. Introduction  
This review describes 81 new natural products from gorgonian corals belonging to the genus 
Junceella (phylum Cnidaria, class Anthozoa, order Gorgonacea, family Ellisellidae) [1–4]. Extending 
from a previous review in 2004 [5], this review describes compounds reported from November 2003 to 
September 2011 and provides structures, names, bioactivities and references for all compounds in 
tabular form.  
2. Natural Products from Gorgonian Corals Belonging to the Genus Junceella 
2.1. Junceella fragilis 
Two new chlorinated briarane-type diterpenoids (3,8-cyclized cembranoids), (−)-2-deacetyl-junceellin 
(1) and (−)-3-deacetyljunceellin (2) (Table 1), along with five known briaranes, junceellin, praelolide, 
and junceellolides A, B and D, were isolated from the gorgonian J. fragilis, collected at the Pass Reef 
of Madang, Papua New Guinea [6]. The absolute stereochemistry of (−)-3-deacetyljunceellin (2) was 
determined by the application of a new method using a combination of proton chemical shifts and 
molecular dynamic calculation.  
Table 1. The new natural products from Junceella fragilis-I. 
Structure No.  Name  Biological  Activity  Ref. 
O
O
H
R1
AcO
O
AcO
Cl
R2
1
2
3
4
5
7
8
9
10
11
12
13
14
15
16
17
18
19
20
6
 
1 
 
2 
 
(−)-2-Deacetyljunceellin  
(R1 = OH, R2 = OAc) 
(−)-3-Deacetyljunceellin  
(R1 = OAc, R2 = OH) 
 
 
n.r. 
a 
 
n.r. 
 
[6] 
 
[6] 
a n.r. = not reported. 
During the past 30 years, a series of interesting and bioactive natural products has been isolated 
from various marine invertebrates collected off the South China Sea [7,8]. Five new briaranes, 
junceellonoids A–E (3–7) (Table 2) [9,10], eight known briaranes, junceellins A and B,   
junceellolides A–D, umbraculolide A and praelolide, along with three known steroids,   
24α-methylcholest-7,22-dien-3β,5α,6β-triol, cholestan-3-ol and cholesterol, were isolated from Mar. Drugs 2011, 9  
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J. fragilis inhabiting the South China Sea [9–12]. Junceellonoids C (5) and D (6) exhibited cytotoxicity 
toward human breast carcinoma MDA-MB-231 and MCF-7 cells [10].  
Table 2. The new natural products from Junceella fragilis-II. 
Structure No.  Name  Biological  Activity Ref. 
O
O
H
AcO
OH
AcO
Cl
OAc OAc  
 
3 
 
 
Junceellonoid A 
 
 
n.r. 
a 
 
 
[9] 
O
O
H
AcO
OH
AcO
OAc
OAc
 
 
 
4 
 
 
Junceellonoid B 
 
 
n.r. 
 
 
[9] 
O
O
H
AcO
O
AcO
Cl
HO OH
O
 
 
5 
 
 
Junceellonoid C 
 
 
exhibited cytotoxicity toward 
MDA-MB-231 and MCF-7 cells 
at a concentration of 100 µM 
 
 
[10] 
O
O
H
AcO
O
AcO
Cl
R1
R2  
6 
 
 
7 
 
Junceellonoid D  
(R1 = R2 = OH) 
 
Junceellonoid E  
(R1 = R2 = OAc) 
 
exhibited cytotoxicity toward 
MDA-MB-231 and MCF-7 cells 
at a concentration of 100 µM 
n.r. 
 
[10] 
 
 
[10] 
a n.r. = not reported. 
In continuing research on the new substances obtained from gorgonian corals distributed in the 
waters of Taiwan at the intersection of the Kuroshio current and the South China Sea surface current, 
the gorgonian J. fragilis was studied to examine the properties of its organic extract. Thirty-one new 
briaranes, 9-O-deacetylumbraculolide A (8) [13], junceellolides H–L (9–13) [14–16], fragilides A–J 
(14–23) [17–24] and frajunolides A–O (24–38) [25–27] (Table 3); 16 known briaranes,   
prarelolide [14,26,28], junceellin A [12,14,26,28], (1R,2R,5Z,7R,8S,9R,10R,12R,14R,17S)-2, 
14-diacetoxy-8,17-epoxide-9,12-dihydroxybriara-5,11(20)-dien-19-one [15], (−)-11β,20β-epoxy-4-
deacetoxyjunceellolide D [16,25,26,29], junceellonoid D [22], juncins Y, Z and ZI [22,26], (+)-11β, Mar. Drugs 2011, 9  
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20β-epoxyjunceellolide D [23,29], junceellolides A–E and K [25,26], and umbraculolide A [25,26]; 
and three known steroids, ergosterol peroxide [26], deoxycholic acid 3,12-diacetate, and deoxycholic 
acid 3,12-diacetate methyl ester [30], were isolated from J. fragilis collected off the waters of Taiwan. 
The structure, including the absolute configuration, of junceellolide J (11) was confirmed by   
single-crystal X-ray diffraction analysis and chemical conversion [16]. Fragilide A (14) was the first 
briarane derivative found to possess a 6-hydroxy group [17]. The geometry of the Δ
3,5(16)-butadiene 
system in fragilide B (15) was found to be of an s-cis form [18]. The 
13C NMR data for the known 
briaranes praelolide and junceellin were reassigned by 2D NMR experiments [14]. 
Table 3. The new natural products from Junceella fragilis-III. 
Structure No.  Name  Biological  Activity  Ref. 
O
O
H
OAc
HO
OH
AcO
 
 
 
8 
 
 
 
 
9-O-Deacetylumbraculolide A 
 
 
 
n.r. 
a 
 
 
[13] 
O
O
H
OH
HO
O
HO
 
 
9 
 
Junceellolide H 
 
not active in cytotoxicity 
testing with P-388D1,  
DLD-1, IMR-32, RPMI 
7951 and CCRF-CEM  
tumor cells 
b  
 
[14] 
O
O
H
OAc
AcO
OH
HO
HO
 
 
 
10 
 
 
Junceellolide I 
 
 
n.r. 
 
 
[15] 
O
O
H
OAc
AcO
OH
AcO
O
O
H
 
 
 
11 
 
 
Junceellolide J 
 
 
not active in  
anti-inflammatory bioassay  
 
 
[16] Mar. Drugs 2011, 9  
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Table 3. Cont. 
O
O
H
OAc
AcO
OH
AcO
O
 
 
 
12 
 
 
Junceellolide K 
 
 
weakly anti-inflammatory  
 
 
[16] 
O
O
H
OAc
AcO
OH
AcO
O
OH
OH
 
 
 
13 
 
 
Junceellolide L 
 
 
not active in  
anti-inflammatory bioassay 
 
 
[16] 
O
O
H
AcO
O
AcO
OH
HO
OAc
AcO  
 
14 
 
 
Fragilide A 
 
 
n.r. 
 
 
[17] 
O
O
H
R1
AcO
OH
AcO
O
Cl R2
 
15 
 
20 
 
Fragilide B  
(R1 = OC(O)CH2CH3, R2 = H)
Fragilide G  
(R1 = R2 = OAc) 
 
weakly anti-inflammatory  
 
not active in cytotoxicity 
testing with DLD-1 and 
CCRF-CEM cells 
 
[18] 
 
[22] 
O
O
H
AcO
O
AcO
Cl
O
R1 R3
R2
 
 
16 
 
 
23 
 
Fragilide C  
(R1 = OCOCH2CH3, R2 = H, 
R3 = OH) 
Fragilide J  
(R1 = OH, R2 = OAc, R3 = H) 
 
weakly anti-inflammatory  
 
 
weakly anti-inflammatory  
 
[19] 
 
 
[24] 
O
O
H
R
AcO
OH
AcO
Cl
O
 
 
 
17 
 
 
Fragilide D (= Frajunolide G) 
(R = OC(O)CH2OC(O) 
CH2CH(CH3)2) 
 
 
n.r.  
 
 
[20,26]Mar. Drugs 2011, 9  
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Table 3. Cont. 
O
O
H
AcO
O
AcO
R1
Cl
AcO
OAc
R2
 
 
18 
 
19 
 
Fragilide E  
(R1 = β-OH, R2 = α-CH2OAc)
Fragilide F  
(R1 = α-OH, R2 = β-CH2Cl) 
 
weakly anti-inflammatory  
 
not active in cytotoxicity 
testing with DLD-1 and 
CCRF-CEM cells  
 
[21] 
 
[22] 
O
O
H
OAc
AcO
O
AcO
OH
OH
Cl
Cl
 
 
21 
 
Fragilide H 
 
not active in cytotoxicity 
testing with P-388D1,  
DLD-1, HL-60 and  
CCRF-CEM cells 
b 
 
[23] 
O
O
H
OAc
R
OH
AcO
OAc
O
 
 
22 
 
Fragilide I 
(R = OC(O)CH2CH(CH3)2) 
 
not active in cytotoxicity 
testing with P-388D1,  
DLD-1, HL-60 and  
CCRF-CEM cells 
 
[23] 
O
O
H
OAc
AcO
OH
AcO
R1
R2
 
24 
 
25 
 
28 
 
33 
 
35 
 
Frajunolide A 
(R1 = α-OAc, R2 = H) 
Frajunolide B 
(R1 = α-OAc, R2 = OAc) 
Frajunolide E 
(R1 = H, R2 = OAc) 
Frajunolide J 
(R1 = α-OC(O)Et, R2 = H) 
Frajunolide L 
(R1 = β-OAc, R2 = H) 
 
weakly anti-inflammatory  
 
weakly anti-inflammatory 
 
frajunolides E, J and L were 
weakly anti-inflammatory  
frajunolides E and J were 
not active in cytotoxicity 
testing with Hep2, Doay, 
WiDr and Hela cells 
b 
[25] 
 
[25] 
 
[26] 
 
[26] 
 
[27] 
O
O
H
OAc
AcO
OH
AcO
O
R
AcO
 
 
26 
 
27 
 
Frajunolide C 
(R = Cl) 
Frajunolide D 
(R = OAc) 
 
weakly anti-inflammatory  
 
not active in  
anti-inflammatory bioassay  
 
[25] 
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Table 3. Cont. 
O
O
H
OAc
AcO
O
AcO
Cl
OH
AcO
 
 
29 
 
Frajunolide F 
 
weakly anti-inflammatory  
not active in cytotoxicity 
testing with Hep2, Doay, 
WiDr and Hela cells 
 
[26] 
O
O
H
R
AcO
OH
AcO
Cl
O
 
 
30 
 
Frajunolide G (= Fragilide D)
(R = OC(O)CH2OC(O) 
CH2CH(CH3)2) 
 
 
not active in  
anti-inflammatory bioassay 
not active in cytotoxicity 
testing with Hep2, Doay, 
WiDr and Hela cells  
 
[20,26]
O
O
H
OAc
AcO
OH
AcO
Cl
AcO
 
31 
 
Frajunolide H 
 
not active in  
anti-inflammatory bioassay 
not active in cytotoxicity 
testing with Hep2, Doay, 
WiDr and Hela cells  
 
[26] 
O
O
H
OAc
AcO
OH
AcO
Cl
AcO
O
 
32 
 
Frajunolide I 
 
weakly anti-inflammatory 
not active in cytotoxicity 
testing with Hep2, Doay, 
WiDr and Hela cells 
 
 
[26] 
O
O
H
R
AcO
OH
AcO
Cl
 
 
 
34 
 
 
Frajunolide K 
(R = OC(O)CH2OC(O) 
CH2CH(CH3)2) 
 
 
 
not active in  
anti-inflammatory bioassay 
 
 
[26] 
O
O
H
OAc
AcO
OH
AcO
AcO
 
 
 
36 
 
 
Frajunolide M 
 
 
weakly anti-inflammatory 
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Table 3. Cont. 
O
O
H
OAc
AcO
OH
AcO
Cl
OH
O
 
 
 
37 
 
 
Frajunolide N 
 
 
modestly anti-inflammatory 
not active in cytotoxicity 
testing with Hep2, Doay, 
WiDr and Hela cells 
 
 
 
[27] 
O
O
H
OAc
AcO
OH
AcO
Cl
AcO
 
 
 
38 
 
 
Frajunolide O 
 
 
weakly anti-inflammatory 
 
 
[27] 
a n.r. = not reported; 
b P388D1 (mouse lymphoid neoplasm), DLD-1 (human colon adenocarcinoma), 
IMR-32 (human neuroblastoma), RPMI 7951 (human malignant melanoma), CCRF-CEM (human  
T-cell acute lymphoblastic leukemia), HL-60 (human promyelocytic leukemia), Hep2 (human liver 
carcinoma), Doay (medulloblastoma), WiDr (human colon adenocarcinoma), Hela (human cervical 
epitheloid carcinoma). 
In order to determine the stereochemistry of briaranes possessing an exocyclic 11,20-epoxy group, the 
13C NMR data of the exocyclic 11,20-epoxy groups have been summarized; these appeared at   
δC 62–63 and 58–60 ppm, respectively, when the epoxy group existed in the 11S* form and led the 
cyclohexane rings to exhibit a twist boat conformation. If the epoxy group was in an 11R* configuration, 
the 
13C NMR data for C-11 and C-20 appeared at δC 55–61 and 47–52 ppm, respectively, and the 
cyclohexane rings were in a chair conformation [16]. The 11,20-epoxybriaranes were only obtained 
from gorgonian corals belonging to the Ellisellidae family, and, thus compounds of this type could be a 
chemical marker for gorgonian corals belonging to the Ellisellidae family [31]. 
From the characteristics of the chemical shifts, it was shown that the briarane derivatives contained 
an exocyclic double bond between C-11/12. The proton chemical shifts were summed up for the olefin 
protons H2-20; these appear at δH 4.95–5.30 and 4.85–5.15 ppm, respectively, when the cyclohexane 
rings are in a twist boat conformation. Likewise, the 
1H NMR data for H2-20 appear at δH 4.95–5.10 
and 4.40–4.75, if the cyclohexane rings were found to exist in a chair conformation [22]. 
Symbiotic algae (zooxanthella) exist throughout the life cycle of J. fragilis, while J. juncea is a 
gorgonian coral free of zooxanthellae [32]. Two known chlorine-containing briaranes, junceellin and 
praelolide, were isolated in the same proportions from both J. fragilis and J. juncea, and this observation 
suggests that junceellin and praelolide could be chemical markers that enable one to infer that the 
briarane-type compounds are originally synthesized by the host corals [28] and are not produced by 
their zooxanthella. Mar. Drugs 2011, 9  
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In biological activity experiments, the new briaranes, junceellolide K (12) [16], fragilides B, C,  
E and J (15, 16, 18, 23) [18,19,21,24], frajunolides A–C (24–26), E (28), F (29), I (32), J (33), L–O  
(35–38) (Table 3), and the known compounds (−)-11β,20β-epoxy-4-deacetoxyjunceellolide D [16,25], 
junceellolide E [25] and umbraculolide A [25], displayed anti-inflammatory activity [33]. Juncin Z was 
found to exhibit cytotoxicity toward CCRF-CEM cells [22].  
2.2. Junceella juncea 
Five new steroidal glycosides, 4′-O-acetyl-3-O-[β-D-arabino-pyranosyl-oxy]-cholest-5-ene-3β,19-diol 
(39) [34] and junceellosides A–D (40–43) [35], and a new glycerol, 1,2-O-[2′-hydroxyoctadecyl]-glycerol 
(44) [34] (Table 4) along with various known metabolites, including four sterols, 24α-methylcholest-7, 
22-dien-3β,5α,6β-triol, 24α-methylcholest-3β,5α,6β-triol-25-monoacetate, 24α-methylcholest-3β,5α, 
6β-triol, and 24α-methylcholest-5,23-dien-3β-ol; six amines, 1-O-β-D-gluco-pyranosyl-(2S,3S,4R, 
8Z)-2-N-(2′-hydroxypalmitoyl)-octadecasphinga-8-ene, (2S,3R)-2-N-palmitoyl-octadecasphinga, (2S, 
3R,4E)-2-N-palmitoyloctadecasphinga-4-ene, thymine, uracil, and adenosine; and batyl alcohol, were 
isolated from the gorgonian coral J. juncea, collected off the South China Sea in 2004–2005 [34,35].  
Table 4. The new natural products from Junceella juncea-IV. 
Structure No.  Name  Ref. 
 
 
 
39 
 
 
40 
41 
42 
43 
 
4′-O-Acetyl-3-O-[β-D-arabino-pyranosyl-oxy]-
cholest-5-ene-3β,19-diol  
(R1 = H, R2 = OH, R3 = OAc) 
Junceelloside A (R1 = R2 = OH, R3 = OAc) 
Junceelloside B (R1 = R3 = OH, R2 = OAc) 
Junceelloside C (R1 = OAc, R2 = R3 = OH) 
Junceelloside D (R1 = R2 = R3 = OH) 
 
[34] 
 
 
[35] 
[35] 
[35] 
[35] 
CH2OH
HC O
CH2O
CHCH(CH2)15CH3
OH  
 
44 
 
1,2-O-[2′-Hydroxyoctadecyl]-glycerol 
 
 
[34] 
In addition, 14 new briarane derivatives, juncins O–Q (45–47) [36], R–ZI (48–57) [37], and ZII  
(58) [38] (Table 5), along with eight known briaranes, praelolide, junceellin, gemmacolides A–C   
and F, junceellolide D [34,38], and (+)-11β,20β-epoxyjunceellolide D [30,38], were also isolated   
from J. juncea.  Mar. Drugs 2011, 9  
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Table 5. The new natural products from Junceella juncea-V. 
Structure No.  Name  Biological  Activity  Ref. 
O
O
H
OAc
AcO
OH
O
Cl
AcO
R
AcO
 
45  Juncin O  
(R = OC(O) 
CH2CH(CH3)2) 
juncins O–Q showed medium antifeedant 
activity (90.7, 69.0, 46.5%) toward the 
second-instar larvae of Spodoptera litura at
a concentration of 500 µg/mL  
juncins O–Q and ZII were not active in 
cytotoxicity testing with K562, A549, Hela 
and Hep2 cells 
a  
medium cytotoxicity (cell mortality:  
8.7% in 24 h and 11.9% in 48 h) toward 
the second-instar larvae of S. litura at a 
concentration of 100 µg/mL 
[36,38]
O
O
H
OAc
AcO
O
AcO
Cl
O
OH
AcO
 
 
46 
 
 
 
 
 
Juncin P  
 
 
 
 
medium cytotoxicity (cell mortality:  
25.3% in 24 h and 29.7% in 48 h) toward 
the second-instar larvae of S. litura at a 
concentration of 100 µg/mL 
 
 
[36,38]
 
 
 
 
O
O
H
OAc
AcO
OH
O
CH2OH
HO
HO
AcO
 
 
47 
 
 
Juncin Q  
 
 
medium cytotoxicity (cell mortality:  
31.3% in 24 h and 44.0% in 48 h) toward 
the second-instar larvae of S. litura at a 
concentration of 100 µg/mL 
 
 
[36,38]
O
O
H
OAc
AcO
OH
O
OAc
OAc
AcO  
 
54 
 
 
Juncin X 
 
 
 
 
 
[37] 
O
O
H
OAc
AcO
OH
R
OAc
AcO
 
 
55 
 
56 
 
Juncin Y  
(R = CH2OAc) 
Juncin Z  
(R = CO(O)CH3)
 
 
 
 
[37] 
 
[37] Mar. Drugs 2011, 9  
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Table 5. Cont. 
O
O
H
R1
AcO
OH
R4
O
R2
R3 R5
 
48 
 
 
 
49 
 
 
 
50 
 
 
 
 
51 
 
 
 
52 
 
 
 
53 
 
Juncin R  
(R1 = R2 = R3 = OAc,  
R4 = OC(O)CH2CH(CH3)2,  
R5 = Cl) 
Juncin S  
(R1 = R3 = R4 = OAc,  
R2 = OC(O)CH2CH(CH3)2,  
R5 = Cl) 
Juncin T  
(R1 = OC(O)CH2OC(O) 
(CH2)2CH(CH3)2, 
R2 = R3 = R4 = OAc,  
R5 = OH) 
Juncin U  
(R1 = R2 = R4 = OAc,  
R3 = OC(O)CH2CH(CH3)2,  
R5 = OCH3) 
Juncin V  
(R1 = R3 = OAc,  
R2 = R4 = OH,  
R5 = OCH3) 
Juncin W  
(R1 = R3 = R5 = OAc,  
R2 = R4 = OH) 
juncins R–ZII (48–58) exhibited 
antifouling activity toward the 
barnacle Balanus amphitrite 
larvae (EC50 = 0.004, 0.3, 2.7, 
1.6, 3.8, 21.1, 0.004, 0.1, 1.5, 0.5 
and 0.004 µg/mL) 
 
 
 
 
 
 
 
[37]
 
 
 
[37]
 
 
 
[37]
 
 
 
 
[37]
 
 
 
[37]
 
 
 
[37]
O
O
H
OAc
AcO
O
AcO
Cl
O
OH
 
 
 
57 
 
 
Juncin ZI 
  
 
[37]
O
O
H
OAc
AcO
OH
AcO
Cl
O
AcO
R
 
58  Juncin ZII  
(R = OC(O)(CH2)2CH(CH3)2) 
 
medium antifeedant activity 
(84.5%) toward the second-instar 
larvae of Spodoptera litura at a 
concentration of 500 µg/mL 
medium cytotoxicity (cell 
mortality: 20.5% in 24 h and 
43.2% in 48 h) toward the 
second-instar larvae of S. litura at 
a concentration of 100 µg/mL 
[38]
a K562 (human erythromyeloblastoid leukemia), A549 (human lung adenocarcinoma), Hela (human cervical 
epitheloid carcinoma), Hep2 (human liver carcinoma). Mar. Drugs 2011, 9  
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In biological activity testing, juncins R–ZII (48–58) showed potent antifouling activities against the 
larval settlement of barnacle Balanus amphitrite at a nontoxic concentration (Table 5), and the 
structure–activity relationships have been discussed [37,38]. The potency of these compounds to 
inhibit larval settlement was increased when the C-16 exocyclic oxymethylene was substituted by a 
methylene-bearing chlorine atom and decreased when the exocyclic oxymethylene C-16 was esterified 
or the acetoxymethylene C-16 was oxygenated to become an esterified group. The chain lengths of the 
ester moieties at C-1, C-12, C-13 and C-14 and the 11,20-epoxy group could also affect the antifouling 
activities [37,38]. 
The known briaranes, gemmacolides A, B, and junceellolide D, were also found to exhibit an 
antifouling activity as potent as that of juncins R–ZII [38], and these three compounds were not 
cytotoxic towards the K562, A549, Hela and Hep2 cells. In addition, all the known briaranes showed 
medium antifeedant activity toward the second-instar larvae of Spodoptera litura at a concentration of 
500 µg/mL [38]. 
The gorgonian J. juncea collected off the Indian Ocean was proven to be a rich source of interesting 
natural products. The ethyl acetate extract of J. juncea exhibited anti-inflammatory activity at 
concentrations of 30–100 mg/kg body weight, while the oral median lethal dose (LD50) for the extract 
in albino mice was above 1000 mg/kg. The ethyl acetate extract of J. juncea also showed antibacterial 
activities toward Bacillus subtilis, B. pumilis and Escherichia coli [39]. Six new briaranes, juncins I–M 
(59–63) [40] and juncenolide B (64) [41], a new sphingolipid, (2R,3R,4E)-1,3-dihydroxy-2-
[(nonadecanoyl) amino]-octadec-4-ene (65) [42] (Table 6), along with four known briaranes, 
gemmacolides A–C and juncin H [40], were obtained from the gorgonian coral J. juncea, collected 
from Tuticorin Coast of the Indian Ocean. 
Table 6. The new natural products from Junceella juncea-VI. 
Structure No.  Name  Biological  Activity Ref. 
O
O
H
OAc
AcO
OH
O
OAc
R3
R1
R2
 
59 
 
 
60 
 
 
61 
Juncin I  
(R1 = R3 = OAc,  
R2 = OCOCH2CH(CH3)2) 
Juncin J  
(R1 = R2 = OCOCH2CH(CH3)2, 
R3 = OAc) 
Juncin K  
(R1 = R3 = OCOCH2CH(CH3)2, 
R2 = H) 
n.r. 
a 
 
 
n.r. 
 
 
n.r. 
[40] 
 
 
[40] 
 
 
[40] 
O
O
H
OAc
OH
O
R3
R1
R2
Cl
AcO
 
62 
 
 
63 
 
 
Juncin L  
(R1 = R2 = OCOCH2CH(CH3)2, 
R3 = OAc) 
Juncin M  
(R1 = R3 = OCOCH2CH(CH3)2, 
R2 = H) 
 
n.r. 
 
 
n.r. 
 
[40] 
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O
O
H
OAc
AcO
OH
O
AcO
R
8
10
11
16
1
 
 
64 
 
 
Juncenolide B 
(R = OCOCH2CH(CH3)2) 
 
 
n.r. 
 
[41] 
OH
OH
NH
O
[]
12
[]
17  
 
65 
 
(2R,3R,4E)-1,3-dihydroxy-2-
[(nonadecanoyl) amino]-octadec-
4-ene 
 
n.r.  
 
[42] 
a n.r. = not reported. 
The molecular formula of juncenolide B was reported as C30H42O11 (M.W. = 578), but the structure 
presented in the article was found to possess the molecular formula C30H42O12 (M.W. = 594). The 
spectral data (such as from NOESY experiments) was not sufficient to support the structure presented 
in the article. We therefore suggested that the structure of this compound (juncenolide B) should be 
reexamined [41]. 
Sixteen new briaranes, juncenolides E–K (66–72) [43–45], juncin N (73) [46], and junceols A–H 
(74–81) [20,47] (Table 7), and two known briaranes, junceellolides B and C, were isolated from   
the gorgonian J. juncea, collected off the waters of Taiwan. Juncenolide G (68) is the first   
naturally-occurring briarane found to have an ether linkage between C-5/C-8 [44], and juncin N (73) is 
the first briarane derivative found to contain a carboxylic group [46].  
Table 7. The new natural products from Junceella juncea-VII. 
Structure No.  Name  Biological  Activity  Ref.
O
O
H
OC(O)CH2CH(CH3)2
AcO
OH
AcO
O
OH
AcO
 
 
66 
 
 
 
Juncenolide E 
 
 
 
 
n.r. 
a 
 
 
[43]
O
O
H
R1
AcO
OH
AcO
Cl
O
R2
 
67 
 
 
69 
 
70 
 
71 
 
Juncenolide F  
(R1 = OC(O)CH(CH3)2,  
R2 = OC(O)CH2CH(CH3)2) 
Juncenolide H  
(R1 = R2 = OAc) 
Juncenolide I  
(R1 = OC(O)CH(CH3)2, R2 = OAc)
Juncenolide J  
(R1 = OAc,  
R2 = OC(O)CH2CH(CH3)2) 
n.r. 
 
 
modestly anti-inflammatory
 
weakly anti-inflammatory  
 
not active in  
anti-inflammatory bioassay
[44]
 
 
[45]
 
[45]
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O
O
H
OAc
AcO
O
AcO
Cl
O
O
OH
 
 
 
 
68 
 
 
Juncenolide G  
 
 
n.r. 
 
 
[44]
O
O
H
OAc
AcO
AcO
O
 
 
 
 
72 
 
 
Juncenolide K 
 
 
weakly anti-inflammatory 
 
 
[45]
O
O
H
AcO
O
AcO
Cl
OH
AcO
OAc
HOOC
 
 
 
 
73 
 
 
Juncin N 
 
 
not active in cytotoxicity 
testing with P-388D1,  
DLD-1, IMR-32, RPMI 
7951 and CCRF-CEM cells 
b
 
 
[46]
O
O
H
OAc
AcO
OH
AcO
R
 
 
 
 
74 
 
 
Junceol A  
(R = OC(O)CH2CH(CH3)2) 
 
 
 
significantly  
anti-inflammatory  
 
 
 
[20]
O
O
H
OC(O)CH(CH3)2
AcO
OH
AcO
Cl R1
R2
O
 
 
 
75 
 
 
76 
 
Junceol B  
(R1 = OAc,  
R2 = OC(O)CH2CH(CH3)2) 
Junceol C  
(R1 = R2 = OC(O)CH2CH(CH3)2)
 
significantly 
anti-inflammatory 
 
significantly 
anti-inflammatory 
 
 
[20]
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O
O
H
R1
AcO
OH
AcO
R3
R2
 
77 
 
 
 
 
78 
 
 
 
79 
Junceol D  
(R1 = OC(O)CH(CH3)2,  
R2 = OC(O)CH2CH(CH3)2,  
R3 = OAc) 
 
Junceol E  
(R1 = OC(O)CH(CH3)2,  
R2 = OAc, R3 = H) 
 
Junceol F  
(R1 = OC(O)CH(CH3)CH2CH3, 
R2 = OAc, R3 = H) 
not active in anti-inflammaory 
bioassay  
exhibited cytotoxicity toward 
CCRF-CEM and DLD-1  
(IC50 = 1.3, 10.0 µg/mL) cells 
weakly anti-inflammatory 
not active in cytotoxicity testing 
with CCRF-CEM and DLD-1 
(IC50 > 40 µg/mL) cells 
moderately anti-inflammatory 
exhibited cytotoxicity toward 
CCRF-CEM (IC50 = 4.9 µg/mL)
cells 
 
[47]
 
 
 
 
[47]
 
 
 
[47]
 
 
O
O
H
R1
AcO
OH
AcO
R3
R2
 
80 
 
 
81 
Junceol G  
(R1 = OC(O)CH(CH3)CH2CH3, 
R2 = H, R3 = OAc) 
Junceol H  
(R1 = OAc, R2 = H,  
R3 =OC(O)CH(CH3)2) 
weakly anti-inflammatory 
exhibited cytotoxicity toward 
CCRF-CEM (IC50 = 4.4 µg/mL)
weakly anti-inflammatory 
exhibited cytotoxicity toward 
CCRF-CEM and DLD-1  
(IC50 = 7.2, 17.0 µg/mL) cells  
[47]
 
 
[47]
 
 
 
a n.r. = not reported. 
b P388D1 (mouse lymphoid neoplasm), DLD-1 (human colon adenocarcinoma), 
IMR-32 (human neuroblastoma), RPMI 7951 (human malignant melanoma), CCRF-CEM (human 
T-cell acute lymphoblastic leukemia). 
3. Conclusions  
The chemical class distribution of the natural products obtained from the organisms Junceella 
fragilis and Junceella juncea compiled in this review indicates that terpenoid derivatives, particularly 
briarane-type diterpenoids, are the major components of the natural products isolated. Of the 81 new 
metabolites, 74 compounds are briarane-type diterpenoids (91.4%). Of these briaranes, over 50% are 
chlorinated briaranes (38/74 = 51.4%), which are rarely found. Briarane-type compounds continue  
to attract attention owing to their structural novelty, complexity and interesting bioactivities, such as 
anti-inflammatory activity [48–51]. Terpenoid compounds are often present in large amounts in marine 
invertebrates, and as a major class represent the largest percentage of natural products isolated from 
marine organisms [52]. Over 500 naturally-occurring briarane derivatives have been isolated from 
various marine organisms [48–51]. However, owing to their structural complexity, it is difficult to 
obtain sufficient amounts of the bioactive metabolites, such as junceols B (75) and C (76), for further 
study of their potential medicinal usage. We have therefore begun to culture the potential useful 
gorgonian corals J. fragilis and J. juncea (Figure 1) in tanks using our highly developed aquaculture 
technology for extraction of natural products to establish a stable supply of bioactive materials, which 
also protects the natural population and habitats from over-exploitation. Mar. Drugs 2011, 9  
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Figure 1. The cultured-type gorgonian corals Junceella fragilis (white) and Junceella juncea (red). 
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